Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Sambrook

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?Philip Sambrook
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Once weekly alendronatePhilip Sambrook
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
EditorialPhilip Sambrook
Clinical Interventions in Aging|November 30, 2007
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal womenPhilip Sambrook
Arthritis Research & Therapy|September 14, 2007
Tumour necrosis factor blockade and the risk of osteoporosis: back to the futurePhilip Sambrook
Lancet (London, England)|May 12, 2005
Vitamin D and fractures: quo vadis?Philip Sambrook
Australian Family Physician|March 10, 2006
Compliance with treatment in osteoporosis patients--an ongoing problemPhilip Sambrook
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2003
Gender differences in volumetric bone density: a study of opposite-sex twinsVasi Naganathan, Philip Sambrook
Best Practice & Research. Clinical Rheumatology|June 14, 2011
EditorialTim Driscoll, Philip Sambrook
BMJ (Clinical Research Ed.)|July 30, 2002
The pharmaceutical industry and disease mongering. Authors were incorrect in their comments about Osteoporosis AustraliaPhilip Sambrook, Judy Stenmark
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?Philip Sambrook
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Once weekly alendronatePhilip Sambrook
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
EditorialPhilip Sambrook
Clinical Interventions in Aging|November 30, 2007
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal womenPhilip Sambrook
Arthritis Research & Therapy|September 14, 2007
Tumour necrosis factor blockade and the risk of osteoporosis: back to the futurePhilip Sambrook
Lancet (London, England)|May 12, 2005
Vitamin D and fractures: quo vadis?Philip Sambrook
Australian Family Physician|March 10, 2006
Compliance with treatment in osteoporosis patients--an ongoing problemPhilip Sambrook
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2003
Gender differences in volumetric bone density: a study of opposite-sex twinsVasi Naganathan, Philip Sambrook
Best Practice & Research. Clinical Rheumatology|June 14, 2011
EditorialTim Driscoll, Philip Sambrook
BMJ (Clinical Research Ed.)|July 30, 2002
The pharmaceutical industry and disease mongering. Authors were incorrect in their comments about Osteoporosis AustraliaPhilip Sambrook, Judy Stenmark
Pageof 4